Personalized & Integrative Medicine: pre-screening before going to the organ-on-a-chip

Innovative 3D in vitro Chemotherapy Screening Platform

🔬 The Challenge:

While organ-on-a-chip platforms offer physiologically relevant environments, they are complex, low-throughput, and costly to scale.
There is a growing need for faster, scalable tools that complement these technologies in early-phase screening.

Our Solution: in perlo^TM Kits

A predictive, plug-and-play 3D cell culture screening technology that enables rapid evaluation of anticancer drug dose responses, including chemotherapies from patient biopsies (only 1 mg needed).

✅ Key Benefits:

High-throughput format: 96-well plate compatibility
3D organoids closer to in vivo tumor structure
Streamlined workflow: no specialized devices required
Complementary to organ-on-chip: ideal for pre-screening large compound libraries

Shown here is a triple-drug screening with three molecules acting on separate pharmacological targets, conducted on MCF-7 breast cancer cell-derived tumoroids.

Technical Request by email @ myproject@pearlbiosystem.com